Latest filing published 02 Mar 2022 for Boston Scientific CORP. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Edward F. Mackey, listed as senior executive, appears in our data through filings on Boston Scientific Corp shares, published by SEC (Form 4). Over a trading history stretching from 1 June 2021 to 28 February 2022, the count stands at 6 filings.
On the market, this insider has only sold: 1 sale, €2.4M in total. The rest of the record consists of 5 option exercises.
The newest entry dates from 2 March 2022: an option exercise, in Boston Scientific Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations